Recurrent Transformed Mycosis Fungoides: Clinical Trials

1 trial for Recurrent Transformed Mycosis Fungoides, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Recurrent Transformed Mycosis Fungoides: new trials by email Literature Review of Recurrent Transformed Mycosis Fungoides trials Research Report on Recurrent Transformed Mycosis Fungoides

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
Parsaclisib, Romidepsin - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Phase 1CompletedWalter Hanel52021-09-012025-01-17

Narrower conditions

Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Cutaneous (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Depsipeptides (1)  ·  Lactones (1)  ·  parsaclisib (1)  ·  romidepsin (1)

Sponsors

Walter Hanel (1)

Countries

United States (1)

Top investigators

Walter Hanel, MD, PhD (1)